[The restless legs syndrome can be treated with dopamine agonists].

[The restless legs syndrome can be treated with dopamine agonists]. Ned Tijdschr Geneeskd (2006) 2.67

Treatment adherence therapy in people with psychotic disorders: randomised controlled trial. Br J Psychiatry (2010) 1.81

Movement disorders should be a criterion for schizophrenia in DSM-V. Psychol Med (2009) 1.42

[Thorn apple poisoning]. Ned Tijdschr Geneeskd (1997) 1.40

[Reaction on 'The aftermath of the reduction in inpatient care and treatment II: cross-sectional study relating to the health, the need for care, the quality of life, social functioning and the integration in society of chronic mental patients in Amsterdam']. Tijdschr Psychiatr (2013) 1.08

Antipsychotic-induced tardive dyskinesia and polymorphic variations in COMT, DRD2, CYP1A2 and MnSOD genes: a meta-analysis of pharmacogenetic interactions. Mol Psychiatry (2008) 1.07

Simultaneous prescribing of atypical antipsychotics, conventional antipsychotics and anticholinergics-a European study. Pharm World Sci (2007) 0.94

Cardiovascular risk factors in outpatients with bipolar disorder. Pharmacopsychiatry (2004) 0.92

Bipolar mania and plasma amino acids: increased levels of glycine. Eur Neuropsychopharmacol (2005) 0.86

Tardive dyskinesia and DRD3, HTR2A and HTR2C gene polymorphisms in Russian psychiatric inpatients from Siberia. Prog Neuropsychopharmacol Biol Psychiatry (2009) 0.83

Lack of relation between culture and anorexia nervosa--results of an incidence study on Curaçao. N Engl J Med (1998) 0.83

Missense polymorphisms in three oxidative-stress enzymes (GSTP1, SOD2, and GPX1) and dyskinesias in Russian psychiatric inpatients from Siberia. Hum Psychopharmacol (2010) 0.83

The role of dopamine D3, 5-HT2A and 5-HT2C receptor variants as pharmacogenetic determinants in tardive dyskinesia in African-Caribbean patients under chronic antipsychotic treatment: Curacao extrapyramidal syndromes study IX. J Psychopharmacol (2008) 0.82

Evaluating interventions to improve somatic health in severe mental illness: a systematic review. Acta Psychiatr Scand (2013) 0.82

Incidence and persistence of tardive dyskinesia and extrapyramidal symptoms in schizophrenia. J Psychopharmacol (2009) 0.81

NMDA receptor genotypes associated with the vulnerability to develop dyskinesia. Transl Psychiatry (2012) 0.81

A cross-sectional study of prescribing patterns in chronic psychiatric patients living in sheltered housing facilities. Int J Clin Pharmacol Ther (2008) 0.79

Movement disorders are associated with schizotypy in unaffected siblings of patients with non-affective psychosis. Psychol Med (2011) 0.79

Nitric oxide and neopterin in bipolar affective disorder. Neuropsychobiology (2006) 0.78

[Suicidal ideations and suicide attempts after starting on aripiprazole, a new antipsychotic drug]. Ned Tijdschr Geneeskd (2006) 0.78

Novel directions for psychiatric diagnosis: from psychopathology to motor function to monitoring technology. Epidemiol Psychiatr Sci (2013) 0.78

[Risk factors for inactivity in patients in long-term care with severe mental illness]. Tijdschr Psychiatr (2013) 0.78

[Chemotherapy during clozapine treatment. Increased risk of agranulocytosis?]. Tijdschr Psychiatr (2008) 0.77

Practical recommendations for improvement of the physical health care of patients with severe mental illness. Acta Psychiatr Scand (2014) 0.77

[Staging and profiling of psychiatric disorders]. Tijdschr Psychiatr (2012) 0.76

[The meaning of cold chills in patients with fever in the emergency facility]. Ned Tijdschr Geneeskd (2002) 0.75

[Alarming admission rates for schizophrenia in migrants from Surinam, the Netherlands Antilles and Morocco]. Ned Tijdschr Geneeskd (1994) 0.75

Aripiprazole in chronic schizophrenia: experiences in daily practice. Acta Psychiatr Scand (2006) 0.75

Tardive dystonia: male:female ratio. Br J Psychiatry (1991) 0.75

[The practice guideline: 'Treatment of tobacco dependence']. Ned Tijdschr Geneeskd (2005) 0.75

[Hemodilution to measure in acute brain infarct using a 20% albumin solution and physiological saline]. Ned Tijdschr Geneeskd (1993) 0.75

Addition of risperidone to clozapine therapy in chronically psychotic inpatients. J Clin Psychiatry (2001) 0.75

[The concealed pill with far-reaching consequences]. Ned Tijdschr Geneeskd (1992) 0.75

[Fewer X-rays, while maintaining quality of care using clinical protocols for physical diagnosis of ankle injuries]. Ned Tijdschr Geneeskd (2000) 0.75

[Risk factors for tardive movement disorders in schizophrenia]. Tijdschr Psychiatr (2015) 0.75

[Departure as editor-in-chief]. Tijdschr Psychiatr (2013) 0.75

Predicting the incidence of antipsychotic-induced movement disorders in long-stay patients: A prospective study. Epidemiol Psychiatr Sci (2013) 0.75

[The genetics of antipsychotic-related movement disorders]. Tijdschr Psychiatr (2015) 0.75

[Scientific research in general psychiatric hospitals]. Tijdschr Psychiatr (2010) 0.75

[Severe treatment-resistant tardive dystonia: is deep brain stimulation a treatment option]. Tijdschr Psychiatr (2015) 0.75

[50 years Journal of Psychiatry]. Tijdschr Psychiatr (2008) 0.75

[acute dystonias in combined abuse of cocaine and neuroleptics]. Ned Tijdschr Geneeskd (1994) 0.75

[The journal in 2012]. Tijdschr Psychiatr (2013) 0.75

[Magic, chemistry and psychiatry]. Tijdschr Psychiatr (2012) 0.75

[The review process, from manuscript to paper]. Tijdschr Psychiatr (2008) 0.75

[The journal in 2011]. Tijdschr Psychiatr (2012) 0.75

[Special issue on staging and profiling: reform of diagnostics]. Tijdschr Psychiatr (2012) 0.75

Tardive dyskinesia is associated with impaired retrieval from long-term memory: the Curaçao Extrapyramidal Syndromes Study: IV. Schizophr Res (2000) 0.75

[Where does the psychiatrist find knowledge?]. Tijdschr Psychiatr (2013) 0.75

Influencing CYP enzymes to boost psychiatric treatment: a review on clinical evidence. Pharmacopsychiatry (2012) 0.75

[Recognition of movement disorders. So what?]. Tijdschr Psychiatr (2011) 0.75

[Hidden diseases: tuberculosis in a woman with a severe mental illness]. Tijdschr Psychiatr (2014) 0.75

[Abuse of anticholinergic agents]. Ned Tijdschr Geneeskd (1990) 0.75

Substantial skin disorders in psychiatric illness coincide with diabetes and addiction. J Eur Acad Dermatol Venereol (2011) 0.75

[Movement disorders as a prodromal sign in individuals at high risk of psychosis]. Tijdschr Psychiatr (2015) 0.75

[The Journal of Psychiatry. A makeover]. Tijdschr Psychiatr (2014) 0.75

Skin disorders in chronic psychiatric illness. J Eur Acad Dermatol Venereol (2010) 0.75

[The journal tijdschrift voor psychiatrie in 2010]. Tijdschr Psychiatr (2011) 0.75

[Write an article!]. Tijdschr Psychiatr (2007) 0.75

[Survey among readers of the Tijdschrift voor Psychiatrie]. Tijdschr Psychiatr (2006) 0.75

[Schizophrenia and antipsychotics associated with the metabolic syndrome. An overview]. Tijdschr Psychiatr (2008) 0.75

Oral risperidone with lorazepam versus oral zuclopenthixol with lorazepam in the treatment of acute psychosis in emergency psychiatry: a prospective, comparative, open-label study. J Psychopharmacol (2005) 0.75

[Psychotropic drugs dispensed on the island of Bonaire]. Tijdschr Psychiatr (2012) 0.75

[Movement disorders in psychiatry]. Tijdschr Psychiatr (2015) 0.75

[Instrumental registration of psychomotor symptoms in schizophrenia: has the time come to use the technique in clinical practice?]. Tijdschr Psychiatr (2015) 0.75

[Malignant neuroleptic syndrome: complete anticoagulant treatment or not?]. Ned Tijdschr Geneeskd (1992) 0.75

[Journey in time]. Tijdschr Psychiatr (2008) 0.75

[Fear of falling in a fall clinic for geriatric patients: a pilot study]. Tijdschr Gerontol Geriatr (2005) 0.75

[Evidence- and practice-based psychiatry]. Tijdschr Psychiatr (2008) 0.75

[The journal in 2009]. Tijdschr Psychiatr (2010) 0.75